Literature DB >> 10430549

Measurement of drug distribution in vascular tissue using quantitative fluorescence microscopy.

W K Wan1, M A Lovich, C W Hwang, E R Edelman.   

Abstract

Quantitative tools to assess vascular macromolecular distributions have been limited by low signal-to-noise ratios, reduced spatial resolution, postexperimental motion artifact, and the inability to provide multidimensional drug distribution profiles. Fluorescence microscopy offers the potential of identifying exogenous compounds within intact tissue by reducing autofluorescence, the process by which endogenous compounds emit energy at the same wavelength as fluorescent labels. A new technique combining fluorescence microscopy with digital postprocessing has been developed to address these limitations and is now described in detail. As a demonstration, histologic cross-sections of calf carotid arteries that had been loaded endovascularly with FITC-Dextran (20 kD) ex vivo were imaged at two different locations of the electromagnetic spectrum, one exciting only autofluorescent structures and the other exciting both autofluorescent elements and exogenous fluorescent labels. The former image was used to estimate the autofluorescence in the latter. Subtraction of the estimated autofluorescence resulted in an autofluorescence-corrected image. A standard curve, constructed from arteries that were incubated until equilibrium in different bulk phase concentrations of FITC-Dextran, was used to convert fluorescent intensities to tissue concentrations. This resulted in a concentration map with spatial resolution superior to many of the previous methods used to quantify macromolecular distributions. The transvascular concentration profiles measured by quantitative fluorescence microscopy compared favorably with those generated from the proven en face serial sectioning technique, validating the former. In addition, the fluorescence method demonstrated markedly increased spatial resolution. This new technique may well prove to be a valuable tool for elucidating the mechanisms of macromolecular transport, and for the rational design of drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430549     DOI: 10.1021/js9803858

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel.

Authors:  Andrew D Levin; Neda Vukmirovic; Chao-Wei Hwang; Elazer R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

2.  A finite element study on variations in mass transport in stented porcine coronary arteries based on location in the coronary arterial tree.

Authors:  Joseph T Keyes; Bruce R Simon; Jonathan P Vande Geest
Journal:  J Biomech Eng       Date:  2013-06       Impact factor: 2.097

3.  Location-dependent coronary artery diffusive and convective mass transport properties of a lipophilic drug surrogate measured using nonlinear microscopy.

Authors:  Joseph T Keyes; Bruce R Simon; Jonathan P Vande Geest
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

4.  Lesion complexity determines arterial drug distribution after local drug delivery.

Authors:  Abraham R Tzafriri; Neda Vukmirovic; Vijaya B Kolachalama; Irina Astafieva; Elazer R Edelman
Journal:  J Control Release       Date:  2009-11-17       Impact factor: 9.776

5.  High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery.

Authors:  Mikhail Y Maslov; Elazer R Edelman; Abraham E Wei; Matthew J Pezone; Mark A Lovich
Journal:  J Control Release       Date:  2013-07-18       Impact factor: 9.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.